首页|左侧乳腺癌保乳术后质子与光子放疗剂量学对比研究

左侧乳腺癌保乳术后质子与光子放疗剂量学对比研究

Comparative study of dosimetry between proton and photon radiotherapy after breast conserving surgery for left breast cancer

扫码查看
目的 比较在深吸气屏气呼吸模式(DIBH)下左侧乳腺癌保乳术后光子调强放疗(IMRT)、质子调强放疗(IMPT)剂量学差异.方法 选取2020年11月至2022年5月中国科学技术大学附属第一医院离子医学中心(合肥离子医学中心)在DIBH模式下接受左侧乳腺癌保乳术后放疗的7例女性患者病历资料,计划靶区(PTV)处方剂量均为50 Gy(5周,25次),对于影像学(包括功能性影像)上高度怀疑有残留或复发病灶的区域局部加量至PTVboost:60 Gy.分别在瓦里安Eclipse 15.5计划系统上设计IMRT计划和Eclipse 16.1计划系统上设计IMPT计划.对2组计划靶区剂量分布、适形指数(CI)、均匀性指数(HI)、两侧肺、健侧乳腺(右乳)、心脏及左冠状动脉前降支(LAD)照射剂量进行统计分析.结果 质子与光子放疗计划相比,PTV最大剂量(Dmax)(P=0.389)和平均剂量(Dmean)(P=0.044)、PTVboostDmax(P=0.226)和 Dmean(P=0.018)、CI(P=0.035)和 HI(P=0.419)、患侧肺部(左侧)Dmax(P=0.153)、健侧肺(右肺)Dmax(P=0.318)和Dmean(P=0.046)、心脏 Dmax(P=0.014)、LADDmax、(P=0.025)、健侧乳腺(右乳)Dmax(P=0.097)均和光子计划无差异.但质子计划左侧肺Dmean(P<0.01)、V5(P<0.001)、V20(P<0.001)及心脏 Dmean(P<0.001)、LAD Dmean(P<0.001)、健侧乳腺(右乳)Dmean(P=0.010)均明显低于光子计划.结论 DIBH下左侧乳腺癌保乳术后质子和光子计划均满足临床要求.但采用质子放疗可显著降低对心脏及其亚单位、患侧肺和健侧乳腺的照射剂量.
Objective To compare photon-modulated radiation therapy(IMRT)and proton-modulated radia-tion therapy(IMPT)after breast-conserving surgery for left breast cancer under deep inspiratory breath-hold(DIBH)dosimetry differences.Methods A total of 7 female patients who received postoperative radiotherapy for left breast cancer in DIBH mode from November 2020 to May 2020 at the First Affiliated Hospital of USTC(Hefei Ion Medical Cen-ter)were selected.The planing target volume(PTV)was prescribed at 50 Gy(5 weeks,25 times),and the local dose was increased to PTVboost:60 Gy for areas with high imaging(including functional imaging)suspicion of residual or re-current lesions.The IMRT plan was designed on the Varian Eclipse 15.5 plan system and the IMPT plan was designed on the Eclipse 16.1 plan system,respectively.The dose distribution,conformal index(CI),homogeneity index(HI),bi-lateral lungs,healthy breast gland(right breast),heart and left anterior descending coronary artery(LAD)of the two groups of planned targets were analyzed statistically.Results Proton versus photon radiation,the maximum dose(Dmax)of PTV(P=0.389)and the mean dose(Dmean)(P=0.044),Dmax of PTVboost(P=0.226)and Dmean(P=0.018),CI(P=0.035)and HI(P=0.419),Dmax of affected lung(left lung)(P=0.153),Dmax of healthy lung(right lung)(P=0.318)and Dmean(P=0.046),Dmax of heart(P=0.014),Dmax of LAD(P=0.025)and Dmax of healthy side breast(right breast)Dmax(P=0.097)were all the same as those in the photon program.However,the left lung Dmean(P<0.01),V5(P<0.001),V20(P<0.001)of the affected side(left lung)of the proton program;Dmean of heart(P<0.001);Dmean of LAD(P<0.001);Dmean of healthy side breast(right breast)(P=0.010)were significantly lower than those of the photon program.Conclusions Both proton and photon programs after breast-conserving surgery for left breast cancer under DIBH meet clinical requirements.However,proton radiotherapy can significantly reduce the irradia-tion dose to the heart and its subunits,the affected lung and the healthy breast.

Breast neoplasmsProton therapyPhotons therapyRadiotherapy dosage

龙腾飞、闻妹、马涛、刘鹤飞、柳璐、李骁扬、张红雁

展开 >

中国科学技术大学附属第一医院离子医学中心(合肥离子医学中心)放疗科,合肥 230088

中国科学技术大学附属第一医院(安徽省立医院)放疗科

乳腺肿瘤 质子疗法 光子疗法 放射治疗剂量

2024

中国临床保健杂志
卫生部北京医院 安徽省保健委员会

中国临床保健杂志

CSTPCD
影响因子:0.931
ISSN:1672-6790
年,卷(期):2024.27(3)
  • 9